Join Now

Category Archives: BioUtah News

First Patient Enrolled in Merit Medical’s MOTION Study

By Natalie Themm | Published January 18, 2024

First Patient Enrolled in Merit Medical’s MOTION Study

| Tagged | Comments Off on First Patient Enrolled in Merit Medical’s MOTION Study

bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

By Natalie Themm | Published January 18, 2024

bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

| Tagged | Comments Off on bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

ENPICOM and Carterra Advance Antibody Screening by Integrating Biophysical Characterization and Repertoire Sequencing Analysis

By Natalie Themm | Published December 20, 2023

By allowing Carterra’s superior epitope, binding affinity, and kinetic information to occupy the same view as sequence information, the IGX Platform enables faster, better decision-making in therapeutic discovery.

| Tagged , | Comments Off on ENPICOM and Carterra Advance Antibody Screening by Integrating Biophysical Characterization and Repertoire Sequencing Analysis

National Registry Names Intermountain Health’s Transplant Program as Nation’s Top Program for Successfully Matching Donated Kidneys to Patients

By Natalie Themm | Published December 20, 2023

National Registry Names Intermountain Health’s Transplant Program as Nation’s Top Program for Successfully Matching Donated Kidneys to Patients

| Tagged | Comments Off on National Registry Names Intermountain Health’s Transplant Program as Nation’s Top Program for Successfully Matching Donated Kidneys to Patients

Merit Medical Announces Process for Chief Executive Officer Succession Planning

By Natalie Themm | Published December 20, 2023

Merit Medical Announces Process for Chief Executive Officer Succession Planning

| Tagged | Comments Off on Merit Medical Announces Process for Chief Executive Officer Succession Planning

Spectrum Solutions Names Bill Phillips as New Chief Executive Officer

By Natalie Themm | Published December 20, 2023

Spectrum Solutions Names Bill Phillips as New Chief Executive Officer

| Tagged | Comments Off on Spectrum Solutions Names Bill Phillips as New Chief Executive Officer

MasterControl Solutions Inc., Expands in Salt Lake County

By Natalie Themm | Published December 20, 2023

$40 million capex, 155 jobs, Project Orange

| Tagged | Comments Off on MasterControl Solutions Inc., Expands in Salt Lake County

Halia Therapeutics Dosed its First Patient in Phase 2a Clinical Trial of HT-6184, a First-in-Class NLRP3-Inhibitor, for the Treatment of Lower-Risk Myelodysplastic Syndromes

By admin | Published December 14, 2023

LEHI, Utah /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced the dosing of the first patient in Phase 2a clinical trial evaluating its lead candidate, HT-6184, for the treatment of lower-risk myelodysplastic syndromes (LR-MDS). HT-6184 is a selective and orally bioavailable first-in-class […]

| Comments Off on Halia Therapeutics Dosed its First Patient in Phase 2a Clinical Trial of HT-6184, a First-in-Class NLRP3-Inhibitor, for the Treatment of Lower-Risk Myelodysplastic Syndromes

BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

By Natalie Themm | Published December 14, 2023

BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations

| Tagged | Comments Off on BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

Halia Therapeutics co-founder David J. Bearss Featured in Utah Business

By Natalie Themm | Published December 14, 2023

Utah Business recently featured Halia Therapeutics co-founder David Bearss in their Founder Series

| Tagged | Comments Off on Halia Therapeutics co-founder David J. Bearss Featured in Utah Business

RxCell Announces $4.6M Investment from DMR Global Venture and Regenosis, Plans for Second Raise of $15M for IND Testing in Q4 2023

By admin | Published December 7, 2023

SINGAPORE–(BUSINESS WIRE)–RxCell, a pioneering biotech company focusing on cellular therapeutics for age-related diseases, today proudly announces a $4,600,000 investment commitment from DMR Global Venture LLC and Regenosis. Building on the strength of collaboration with National University of Singapore, this fresh investment accentuates RxCell’s resolute drive to revolutionize age-related disease treatment. “We’re thrilled to align with […]

| Comments Off on RxCell Announces $4.6M Investment from DMR Global Venture and Regenosis, Plans for Second Raise of $15M for IND Testing in Q4 2023

Culmination Bio Raises $10M From Amgen Ventures and Merck Global Health Innovation Fund to Bring Longitudinal Health Data to Biopharma

By admin | Published December 7, 2023

Culmination Bio has over 40 years of biospecimen data and counting, paired with clinical data from patient EHRs, making recruitment for pharmaceutical research almost instantaneous. St. George, Utah — (November 30, 2023) — Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health […]

| Comments Off on Culmination Bio Raises $10M From Amgen Ventures and Merck Global Health Innovation Fund to Bring Longitudinal Health Data to Biopharma

A Special Thanks To Our Legacy and Platinum Elite Members